Evidence map›Paper›PMID 22211188›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2011

Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function.

David O Kennedy, Emma L Wightman

Abstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 164 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
164citing papers in PubMed, 2 pooled it
82.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

164 citing papers in PubMed, 2 syntheses or guidelines pooled it, 665 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Neurological Effects ofNutrients · 2026
    Article
  5. Article
  6. Review
  7. The acute effects of Zensera™ (Therapeutic advances in psychopharmacology · 2026
    Article
  8. Innovative Approaches to Extracting Phenolics fromFoods (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. OptimizedJournal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2025
    Article
  14. Unveiling the Therapeutic Potential ofBioMed research international · 2025
    Article
  15. Article
  16. Phytophenols as Promoieties for Prodrug Design.Current drug discovery technologies · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Article

104 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David O KennedyBrain, Performance and Nutrition Research Centre, School of Life Sciences, Northumbria University, Newcastle, UK. david.kennedy@northumbria.ac.uk
Emma L Wightman
Northumbria University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humans consume a wide range of foods, drugs, and dietary supplements that are derived from plants and which modify the functioning of the central nervous sytem (CNS). The psychoactive properties of these substances are attributable to the presence of plant secondary metabolites, chemicals that are not required for the immediate survival of the plant but which are synthesized to increase the fitness of the plant to survive by allowing it to interact with its environment, including pathogens and herbivorous and symbiotic insects. In many cases, the effects of these phytochemicals on the human CNS might be linked either to their ecological roles in the life of the plant or to molecular and biochemical similarities in the biology of plants and higher animals. This review assesses the current evidence for the efficacy of a range of readily available plant-based extracts and chemicals that may improve brain function and which have attracted sufficient research in this regard to reach a conclusion as to their potential effectiveness as nootropics. Many of these candidate phytochemicals/extracts can be grouped by the chemical nature of their potentially active secondary metabolite constituents into alkaloids (caffeine, nicotine), terpenes (ginkgo, ginseng, valerian, Melissa officinalis, sage), and phenolic compounds (curcumin, resveratrol, epigallocatechin-3-gallate, Hypericum perforatum, soy isoflavones). They are discussed in terms of how an increased understanding of the relationship between their ecological roles and CNS effects might further the field of natural, phytochemical drug discovery.

Indexed as

AnimalsAntioxidantsBrainFlavonoidsGinkgo bilobaHumansInsectaMelissaPanaxPhenolsPhytotherapyPlant ExtractsPlant Physiological PhenomenaPlantsSalvia officinalisAntioxidantsFlavonoidsPhenolsPlant Extracts

Identifiers

PMID22211188
PMCPMC3042794
OpenAlexW2158258935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.